About Prilenia
prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders. our lead asset is pridopidine, a first-in-... Read more
prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders. our lead asset is pridopidine, a first-in-... Read more